Less weight. More everything else.
Physician-led GLP-1 weight loss. Full metabolic panel. Dose titrated to your labs. Medication in 14 days.
- Compounded semaglutide, or branded Ozempic® / Zepbound®.
- Physician reviews a full metabolic panel first.
- Dose escalated and monitored every 90 days.
Free physician consultation before any prescription.
Top responders
Up to 22%
Body weight on semaglutide 2.4mg at 68 weeks — top quartile.
STEP 1 · Wilding, NEJM 2021
The treatment gap
This isn’t a willpower problem. It’s a medicine gap.
You’ve tried the diets. Your PCP told you to try again. GLP-1s treat the biology diets can’t reach.
42%
of U.S. adults have obesity or severe obesity.
CDC NHANES, 2021–2023
5+ diets
the average adult tries before considering medication.
International Journal of Obesity, 2022
<1%
of eligible patients are offered prescription weight care.
Gasoyan et al., Obesity, 2022
What we test before prescribing
Every protocol starts with a full metabolic panel. Not just BMI.
The science
GLP-1s don’t suppress appetite. They restore it.
Slower gastric emptying. Stronger satiety signaling. Better insulin response. Your body learns what full feels like again. Wilding et al., NEJM, 2021.
Mechanism
Slower emptying
Food stays in your stomach longer. You feel full on less.
Mechanism
Satiety signal
GLP-1 receptors in your brain register fullness earlier and longer.
Mechanism
Insulin response
Blood sugar stabilizes. Fewer crashes. Fewer cravings.
What does six months look like?
Drag the sliders. Watch the projection move in real time. Math reflects realistic GLP-1 outcomes — protocol still gets designed by your physician.
Real outcomes vary. Your physician sets the actual protocol from your labs and history.
What changes
Food noise, quiet. Cravings, handled. Plateaus, ended.
Hover or tap. See what changes.
Your options
Three paths. Same physicians.
Compounded GLP-1s are significantly more affordable and in stock. Branded options are FDA-approved and may be covered by insurance. Your physician helps you pick.
Compounded Semaglutide
- Same active ingredient as Ozempic®
- Weekly subcutaneous injection
- Titrated over 16 weeks
Branded Ozempic®
- FDA-approved branded semaglutide
- Flat monthly pricing — no founding discount
- Requires current prescription
Branded Zepbound®
- FDA-approved tirzepatide (dual GLP-1 / GIP agonist)
- Flat monthly pricing — no founding discount
- Requires current prescription
Compounded medications are not FDA-approved as finished products. They are prepared by US-licensed 503A pharmacies under USP 797 standards. Not available in all 50 states.
The protocol
Dose up gradually. Minimize side effects.
Semaglutide titration typically runs 16 weeks to maintenance. Your physician adjusts based on your tolerance and response.
Wk 1–4
0.25 mg
Starting dose
Wk 5–8
0.5 mg
First escalation
Wk 9–12
1.0 mg
Building tolerance
Wk 13–16
1.7 mg
Second escalation
Wk 17+
2.4 mg
Maintenance
The difference
Weight loss done like medicine.
What you’d get at quick-Rx telehealth or a GP, vs what you get at Halo.
Halo
Your protocol
Typical telehealth
Or your PCP
What to expect
Real numbers. Real trials. Not marketing.
Body weight
mean body weight reduction at 68 weeks on semaglutide 2.4 mg — with up to ~34 lbs lost in the STEP 1 trial (N=1,961).
Wilding et al., NEJM, 2021 (STEP 1)
Food noise
drop in the share of patients reporting constant food-related thoughts after starting semaglutide — a 46-point reduction in the INFORM patient survey (N=550).
INFORM survey, Novo Nordisk, EASD 2025
HbA1c (T2D)
percentage-point HbA1c reduction in adults with type 2 diabetes on semaglutide 2.4 mg over 68 weeks.
Davies et al., Lancet, 2021 (STEP 2)
Your physician
A metabolic specialist.
Not a weight-loss mill.
Halo physicians are board-certified internists and endocrinologists with specific training in metabolic health, GLP-1 titration, and side-effect management.
Terms
Everything included. Membership, medication, labs.
Founding price · compounded GLP-1
What’s included
- Initial physician consultation
- Full baseline metabolic panel
- Compounded GLP-1 medication
- Physician-designed dose titration
- Async physician access
- Follow-up labs at 90 days
- Injection supplies included
No contracts. Cancel anytime.
Questions
Everything worth asking.
Adults with a BMI over 27 (with metabolic risk factors) or over 30. We start with a full metabolic panel to confirm you’re a candidate — not just a weight number.
Our compounded semaglutide uses the same active ingredient as branded Ozempic®, prepared by a US-licensed 503A pharmacy. It’s not FDA-approved as a finished product, but the active ingredient and pharmacy standards are. Compounded is significantly less expensive and in stock. If you prefer the branded route, we offer Ozempic® and Zepbound® direct-pay.
Most common: nausea, constipation, heartburn, fatigue — usually during dose escalation. Serious but rare: pancreatitis, gallbladder issues. Not appropriate if you have a personal or family history of MTC or MEN 2 syndrome. Your physician screens for this up front.
Most people who stop GLP-1s regain the weight over 12–18 months. That’s biology, not willpower. Some patients taper to a lower maintenance dose. Others stay on 2.4mg indefinitely. Your physician walks you through the tradeoffs.
Maybe. Branded Ozempic® and Zepbound® are sometimes covered when prescribed for an FDA-approved indication. Compounded semaglutide isn’t insurance-billed but is significantly less expensive. We handle prior authorization paperwork for the branded route if you want to try your insurance first.
Most people see 1–2 lbs per week during dose escalation. Full results accrue over 6–12 months. Semaglutide averages ~15% of body weight at 68 weeks in published trials.
HbA1c, fasting insulin, fasting glucose, full lipid panel, ApoB, hs-CRP, TSH, free T4, liver enzymes (ALT, AST), kidney function (creatinine, eGFR), CBC, vitamin D, B12, and sex hormones. Follow-up at 90 days.
Yes. No contracts. Cancel through your member portal or by emailing your care team. Your prescription continues through the current shipment cycle.
Weight loss, measured
Less weight. More everything else.
First physician consultation is free. No commitment until your physician reviews your metabolic panel.
Start my assessmentHalo is a technology platform that connects patients with licensed healthcare providers. All clinical decisions are made by independent licensed providers. Individual results vary. Not medical advice. Compounded drug products are not FDA-approved or evaluated. GLP-1 medications may cause nausea, vomiting, diarrhea, pancreatitis, or gallbladder issues. Not for personal or family history of MTC or MEN 2 syndrome. Rx required. Not available in all 50 states.
Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Zepbound® is a registered trademark of Eli Lilly and Company. Halo is not affiliated with, endorsed by, or sponsored by either manufacturer. Important Safety Information · Wegovy® · Ozempic® · Zepbound®.